Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Drug resistance Topoisomerases

Idoxuridine, Antiviral thymidine analog (ab142581)

Key features and details

  • Antiviral thymidine analog Radiosensitizer. Anticancer
  • CAS Number: 54-42-2
  • Purity: > 98%
  • Soluble in water to 5 mM
  • Form / State: Solid
  • Source: Synthetic

You may also be interested in

Product image
CPT 11 (Irinotecan), DNA topoisomerase I inhibitor (ab141107)
Product image
Anti-Topoisomerase I antibody [EPR5375] (ab109374)
Sanguinarine chloride, PP2C inhibitor (ab141022)
Product image
Anti-Topoisomerase I antibody (ab245431)

Overview

  • Product name

    Idoxuridine, Antiviral thymidine analog
  • Description

    Antiviral thymidine analog Radiosensitizer. Anticancer
  • Alternative names

    • (+)-5-Iodo-2'-deoxyuridine
    • IdU
  • Biological description

    Selective cytotoxic cell-permeable anti-herpesvirus agent (IC50 = 4.3 μM). Radiosensitizing. Incorporates into DNA increases susceptibility of cancer cell to radiation damage. Active in vivo.

  • Purity

    > 98%
  • CAS Number

    54-42-2
  • Chemical structure

    Chemical Structure

Properties

  • Chemical name

    1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione
  • Molecular weight

    354.10
  • Molecular formula

    C9H11IN2O5
  • PubChem identifier

    5905
  • Storage instructions

    Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
  • Solubility overview

    Soluble in water to 5 mM
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILES

    C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O
  • Source

    Synthetic

  • Research areas

    • Epigenetics and Nuclear Signaling
    • DNA / RNA
    • DNA Synthesis
    • Topoisomerases
    • Epigenetics and Nuclear Signaling
    • DNA / RNA
    • DNA Synthesis
    • Other
    • Biochemicals
    • Chemical Type
    • Biochemicals
    • Biochemicals
    • Pharmacology
    • Signaling
    • DNA, RNA & protein synthesis
    • DNA & RNA synthesis

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Methylmalonyl Coenzyme A mutase antibody [EPR7738] (ab134956)

  •  
  • Product image

    Anti-C5 / C5b antibody [EPR23940-3] (ab275931)

  •  
  • Product image

    Anti-IgG1 + IgG2a + IgG3 antibody [M204-3] (ab133469)

  •  
  • Product image

    Anti-Topoisomerase II alpha (phospho S1106) antibody [EP2722] (ab75765)

  •  
  • Product image

    Anti-Alpha-synuclein (phospho Y125) antibody [EPR2179(2)] (ab124955)

  •  
  • Product image

    Anti-PAK1+PAK2+PAK3 (phospho S141 + S144 + S154) antibody [EP656Y] - BSA and Azide free (ab239830)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.